Alberta's Orpyx Medical Technologies developed SurroSense Rx as an FDA-approved foot sensor technology system for supporting foot health. In particular, the system is beneficial for predicting potential risks to foot health, like diabetic foot wounds, and reporting them to a smartwatch.
The sensor-embedded shoe inserts for running and walking shoes are designed to intake pressure data and keep tabs on dangerous conditions. When a user receives an alert that their foot health may be at risk due to time and pressure levels, they are able to bring their attention to changing their behaviors and taking steps towards better health. Over time, users are able to consult digital data charts on their personalized Orpyx Connect account.
As diabetes can lead to nerve damage and a loss of sensation in the foot, people who suffer from this disease are at risk of developing foot ulcers that may lead them to become candidates for limb amputation in extreme cases.